Walleye Capital
NEXI

Walleye Capital’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Walleye Capital’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,286
Closed -$525 – 1863
2021
Q2 		$525 Sell
1,286
-314
-20% -$145K 0.02% 731
2021
Q1 		$763 Buy
+1,600
New +$871K 0.04% 395

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Walleye Capital's NEXI Position: Q3 2021 in Review

Walleye Capital sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2021, closing a stake of 1,286 shares — an estimated $525 sold.

Walleye Capital first reported a position in NEXI in Q1 2021 and held it in 2 quarters. The position peaked at $763 in Q1 2021. 47 funds tracked by Wall St. Rank hold NEXI as of Q3 2021.

  • Walleye Capital reported no remaining NexImmune, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Walleye Capital sold 1,286 NexImmune, Inc. Common Stock shares in Q3 2021, an estimated $525.
  • Walleye Capital first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Walleye Capital's NexImmune, Inc. Common Stock position peaked at $763 in Q1 2021.
  • 47 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2021.

Based on Walleye Capital's 13F filing for Q3 2021, filed 15 Nov 2021.